Medication Use and the 5-Year Incidence of Early Age-Related Maculopathy: The Beaver Dam Eye Study
Open accessAbstract
Objective To evaluate incident early age-related maculopathy (ARM) after a 5-year interval with respect to medication use. Design Population-based incidence study. Setting Participants were adults aged 43 to 86 years living in Beaver Dam, Wis, when first examined in 1988-1990 (n = 4926); they were reexamined in 1993-1995(n = 3684). Methods All participants were examined and interviewed and stereoscopic color fundus photographs were taken. All procedures were done by standard protocol at both examinations. Incidence of ARM was based on grading using the Wisconsin ARM Grading System. All prescribed and over-the-counter medications in current use were brought to the examination site and the names were recorded at that time. Results There were 678 drug preparations (active ingredients) being used at the baseline examination. No relations were found between most antihypertensive drugs, most central nervous system medications, aspirin and other nonsteroidal anti-inflammatory agents, estrogens, lipid-lowering agents, and incident early ARM over the 5-year period. Age- and sex-adjusted logistic regression analyses suggested possible associations (P<.10) between the use of phenothiazine antidopaminergics (odds ratio [OR], 2.83; 95% confidence interval [CI], 0.97-8.23;P= .06), desiccated thyroid hormones (OR, 2.32; 95% CI, 0.89-6.07;P= .09), and calcium channel blockers (OR, 1.70; 95% CI, 0.93-3.12;P= .08) with incident ARM. When additional information on past use was included in the regression model, the association remained for calcium channel blockers, but not for phenothiazines and desiccated thyroid hormones. A lower incidence of early ARM occurred in those who took antidepressants(OR, 0.34; 95% CI, 0.12-0.94;P= .04) at the baseline examination. Conclusion Although many different medications were being used at the baseline examination in the Beaver Dam Eye Study cohort, there were no striking associations with the 5-year incidence of early ARM.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Results from the Beaver Dam Study suggest that people who spent leisure time outdoors were at an increased risk of developing early age-related macular degeneration.
“Results from the Beaver Dam Study suggest that people who spent leisure time outdoors were at an increased risk of developing early age-related macular de generation.113”
From Age-related macular degeneration (2008) · cites this paper as [113]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
No adjustments are needed for multiple comparisons.
Rothman, K. J. (1990) · Epidemiology · doi:10.1097/00001648-199001000-00010 · Cited by 5,965 · see citing works
Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel- Haenszel Procedure
Mantel, N. (1963) · Journal of the American Statistical Association · doi:10.1080/01621459.1963.10500879 · Cited by 2,899 · see citing works
Prevalence of age-related maculopathy
Klein, R., Klein, B. E. K., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31871-8 · Cited by 1,845 · see citing works
The Wisconsin Age-related Maculopathy Grading System
Klein, R., Davis, M. D., Magli, Y. L., Segał, P., Klein, R., & Hubbard, L. D. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32186-9 · Cited by 1,188 · see citing works
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, R., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,148 · see citing works
The Beaver Dam Eye Study: Visual Acuity
Klein, R., Klein, R., Linton, K. L. P., & Mets, D. L. D. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32137-7 · Cited by 663 · see citing works
The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity.
Klein, R., Wang, Q., Klein, R., Moss, S. E., & Meuer, S. M. (1995) · PubMed · Cited by 461 · see citing works
Risk Factors of Age-related Maculopathy in a Population 70 Years of Age or Older
Hirvelä, H., Luukinen, H., Läärä, E., & Laatikainen, L. (1996) · Ophthalmology · doi:10.1016/s0161-6420(96)30593-9 · Cited by 183 · see citing works
Massive Hemorrhage Complicating Age-Related Macular Degeneration
Baba, F. E., Jarrett, W. H., Harbin, T. S., Fine, S. L., Michels, R. G., SCHACHAT, A. P., & Green, W. R. (1986) · Ophthalmology · doi:10.1016/s0161-6420(86)33540-1 · Cited by 156 · see citing works
Linton, K. L. P., Klein, R., & Klein, R. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116049 · Cited by 147 · see citing works
Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians
Christen, W. G., Manson, J. E., Glynn, R. J., Ajani, U. A., Schaumberg, D. A., Sperduto, R. D., Buring, J. E., & Hennekens, C. H. (1998) · Ophthalmic Epidemiology · doi:10.1076/opep.5.3.133.8368 · Cited by 38 · see citing works
Senile cataract and senile macular degeneration: an investigation into possible risk factors.
Gibson, J. M., Shaw, D. E., & Rosenthal, A. R. (1986) · PubMed · Cited by 35 · see citing works
Posterior subcapsular cataracts and macular lesions after long-term corticotrophin therapy.
Williamson, J. M., & Dalakos, T. G. (1967) · British Journal of Ophthalmology · doi:10.1136/bjo.51.12.839 · Cited by 24 · see citing works
Changes in Visual Acuity in a Population: The Beaver Dam Eye Study
Weissman, B. A. (2001) · Evidence-Based Eye Care · doi:10.1097/00132578-200107000-00018 · Cited by 23 · see citing works
Flagged first, then by citations
Research works printed but not linked: 8
- Tielsch JA. Vision problems in the US: a report on blindness and vision impair- ment in adults age 40 and older. Prevent Blindness America. Schaumburg, Ill: Prevent Blindness Inc; 1995:1-20.
- Eagle RJ. Mechanism of maculopathy. Ophthalmology. 1984;91:613-625.
- Friedman E. Pathogenesis: a hemodynamic model. In: Berger JW, Fine SL, Maguire MG, eds. Age-Related Macular Degeneration. St Louis, Mo: Mosby; 1999:173-178.
- Klein R. Epidemiology. In: Berger JW, Fine SL, Maguire MG, eds. Age-Related Macular Degeneration. St Louis, Mo: Mosby; 1999:31-56.
- Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the Age-Related Eye Disease Study (AREDS Report No. 3). Ophthalmology. 2000;107:2224-2232.
- Zinn KM, Marmor MF. Toxicology of the human retinal pigment epithelium. In: Zinn KM, Marmor MF, eds. The Retinal Pigment Epithelium. Cambridge, Mass: Harvard University Press; 1979:395-412.
- Diabetic Retinopathy Study Research Group. Report 7: a modification of the Air- lie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci. 1981; 21:210-226.
- SAS Institute. SAS User's Guide: Statistics, Version 8 Edition. Cary, NC: SAS In- stitute; 1999.
Cited by
Sorted by citations
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959 · see citing works
The epidemiology of age-related macular degeneration
Klein, R., Peto, T., Bird, A., & Vannewkirk, M. R. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.069 · Cited by 932 · see citing works
Self-citationAge-related macular degeneration
Coleman, H. R., Chan, C.-C., Ferris, F. L., & Chew, E. Y. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61759-6 · Cited by 542 · see citing works
A new perspective on lipid research in age-related macular degeneration
van Leeuwen, E. M., Emri, E., Merle, B. M. J., Colijn, J. M., Kersten, E., Cougnard-Gregoire, A., Dammeier, S., Meester-Smoor, M., Pool, F. M., de Jong, E. K., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.006 · Cited by 247 · see citing works
Klein, R., Deng, Y., Klein, B. E. K., Hyman, L., Seddon, J., Frank, R. N., Wallace, R. B., Hendrix, S. L., Kuppermann, B. D., Langer, R. D., et al. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.11.058 · Cited by 142 · see citing works
The association between statin use and age related maculopathy
McGwin, G. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.9.1121 · Cited by 138 · see citing works
Inflammation, Complement Factor H, and Age-Related Macular Degeneration
Klein, R., Knudtson, M. D., Klein, B. E. K., Wong, T. Y., Cotch, M. F., Liu, K., Cheng, C. Y., Burke, G. L., Saad, M. F., Jacobs, D. R., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.03.021 · Cited by 106 · see citing works
Self-citationKaur, G., Tan, L. X., Rathnasamy, G., La Cunza, N., Germer, C. J., Toops, K. A., Fernandes, M., Blenkinsop, T. A., & Lakkaraju, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805039115 · Cited by 79 · see citing works
Therapeutic Potential of Statins in Age-related Macular Degeneration
Shahsuvaryan, M. L. (2011) · Sierra Leone Journal of Biomedical Research · doi:10.4314/sljbr.v3i2.71807
Complex mutations of USH2A gene denote ARRP
(2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.9.1125
- Authors
- Klein, R.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Klein, Ronald
- ORCID
- Klein, Ronald
- Venue
- Archives of Ophthalmology
- Publisher
- American Medical Association (AMA)
- Published
- 2001-09-01
- Volume
- 119
- Issue
- 9
- Pages
- 1354
- ISSN
- 0003-9950 (ISSN-L)
- OpenAlex
- W1528210742
- Cited by
- 3
- References
- 14
- FWCI
- 0.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Archives of Ophthalmology (publishedVersion)
- Funders
- National Eye Institute (EY0-6594)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- age-related maculopathy, medication use, drug-induced maculopathy, phenothiazines, calcium channel blockers, antidepressants, antihypertensive drugs, nonsteroidal anti-inflammatory drugs, aspirin, estrogen, lipid-lowering drugs, central nervous system drugs, incidence, Beaver Dam Eye Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
